Physician profile
Mark A Wayne
NPI 1447220587
$1,184.51
in general payments reported to CMS, 2019-2025
17 companies · $51.13 in 2025
The $51.13 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $161 · 2021: $236 · 2022: $205 · 2023: $177 · 2024: $96.85 · 2025: $51.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $327.11 | 2019-2025 | Dyanavel Xr |
| Pfizer INC. | $209.19 | 2019-2025 | |
| Corium, LLC | $103.18 | 2021-2023 | Azstarys |
| Supernus Pharmaceuticals, INC. | $90.95 | 2021-2023 | Qelbree |
| Adlon Therapeutics L.P. | $77.21 | 2019-2021 | |
| Cranial Technologies, INC | $65.25 | 2019-2023 | Doc Band |
| Glaxosmithkline, LLC. | $61.53 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $56.20 | 2022-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sobi, INC | $38.38 | 2020-2022 | |
| Ironshore Pharmaceuticals INC. | $30.89 | 2019 | |
| Shire North American Group INC | $24.72 | 2019 | |
| Sarepta Therapeutics, INC. | $17.91 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $17.80 | 2023 | Flumist Quadrivalent |
| Ultragenyx Pharmaceutical INC. | $17.66 | 2021 | |
| Dermira, INC. | $16.52 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $15.18 | 2021 | |
| Seqirus USA INC | $14.83 | 2025 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wayne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.